First Amendment Case Law Allows FDA To Dictate Warnings – AARP
First Amendment case law leaves FDA with ample authority to require specific warnings in product promotions, AARP maintains
You may also be interested in...
FDA will base its regulation of product labeling "on the science about how the public understands and interprets information on labels," Commissioner-nominee Mark McClellan told the Senate Health Committee Oct. 7
FDA should allow manufacturers to choose the exact wording of required substantive information in their labels, 1Pfizer's comments on First Amendment issues state
FDA is requesting comment on the legal underpinnings for arguing that promotions of prescription drugs can be more tightly regulated than those for other products